BGIM
CANO

Boussard & Gavaudan Investment Management’s Cano Health, Inc. CANO Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,537
Closed -$2.08M – 100
2020
Q4 		$2.08M Sell
1,537
-3,213
-68% -$3.67M 0.3% 34
2020
Q3 		$4.99M Buy
+4,750
New +$4.97M 0.64% 24

Other funds holding CANO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CANO Position: Q1 2021 in Review

Boussard & Gavaudan Investment Management sold out of Cano Health, Inc. (CANO) in Q1 2021, closing a stake of 1,537 shares — an estimated $2.08M sold.

Boussard & Gavaudan Investment Management first reported a position in CANO in Q3 2020 and held it in 2 quarters. The position peaked at $4.99M in Q3 2020. 71 funds tracked by Wall St. Rank hold CANO as of Q1 2021.

  • Boussard & Gavaudan Investment Management reported no remaining Cano Health, Inc. position as of Q1 2021 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 1,537 Cano Health, Inc. shares in Q1 2021, an estimated $2.08M.
  • Boussard & Gavaudan Investment Management first reported a position in Cano Health, Inc. in Q3 2020 and held it in 2 quarters.
  • Boussard & Gavaudan Investment Management's Cano Health, Inc. position peaked at $4.99M in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2021, filed 11 May 2021.